Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance

Yusuke Takahashi, Takashi Eguchi, Koji Kameda, Shaohua Lu, Raj G. Vaghjiani, Kay See Tan, William D. Travis, David R. Jones, Prasad S. Adusumilli

Research output: Contribution to journalArticlepeer-review


Background: We hypothesize that recurrence hazard following resection for stage I-IIA lung adenocarcinoma (ADC) varies according to histologic subtype, which may provide risk stratification for surveillance better than the current uniform follow-up protocol. Results: Presence (≥5%) of high-grade histologic subtypes (MIP and/or SOL) was associated with a significantly higher recurrence hazard: (1) presence of either MIP or SOL was associated with a significant increase in recurrence hazard during the first two years after surgery; (2) presence of SOL was associated with an increase in recurrence hazard-in particular, distant recurrence hazard-during the first year after surgery; (3) absence of high-grade subtypes (515/1,572 patients) was associated with a very low recurrence hazard (<2% risk/year) during the first ten years after surgery. Methods: All hematoxylin and eosin-stained tumor slides from pathologic stage I-IIA lung ADC (n = 1572) were reviewed for quantification of the percentage of each histological subtype. Recurrence hazard was estimated using the Kernel-Epanechnikov smoothing procedure. The association between recurrence hazard and high-grade histologic subtypes (micropapillary [MIP] and solid [SOL]) was assessed. Conclusions: Our findings suggest that histologic subtyping has utility for identifying recurrence hazard for surgically resected stage I-IIA lung ADC patients and provide rationale for establishing risk-based surveillance.

Original languageEnglish (US)
Pages (from-to)35742-35751
Number of pages10
Issue number87
StatePublished - Nov 1 2018
Externally publishedYes


  • Dynamics
  • Micropapillary
  • Prognosis
  • Recurrence hazard
  • Solid

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance'. Together they form a unique fingerprint.

Cite this